CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 864 of 1
Non-Antibody Products
Page 864 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| O-Acetyl Salicylhydroxamic Acid | O-ASHA is an irreversible, non-selective inhibitor of COX-1 and COX-2. Asp… | 5 mg | 70263-5 | More Info |
| O-Acetyl Salicylhydroxamic Acid | O-ASHA is an irreversible, non-selective inhibitor of COX-1 and COX-2. Asp… | 50 mg | 70263-50 | More Info |
| 3'-O-Acetylthymidine-5'-O-triphosphate (sodium salt) | An acetylated derivative of 2'-deoxythymidine-5'-triphosphate | 2.6 mg | 38634-26 | More Info |
| 10-OAHSA | A FAHFA in which oleic acid is esterified to 10-hydroxy stearic acid | 1 mg | 19975-1 | More Info |
| 10-OAHSA | A FAHFA in which oleic acid is esterified to 10-hydroxy stearic acid | 10 mg | 19975-10 | More Info |
| 10-OAHSA | A FAHFA in which oleic acid is esterified to 10-hydroxy stearic acid | 5 mg | 19975-5 | More Info |
| 12-OAHSA | A FAHFA in which oleic acid occurs at the 12-position on hydroxy stearic a… | 1 mg | 17108-1 | More Info |
| 12-OAHSA | A FAHFA in which oleic acid occurs at the 12-position on hydroxy stearic a… | 10 mg | 17108-10 | More Info |
| 12-OAHSA | A FAHFA in which oleic acid occurs at the 12-position on hydroxy stearic a… | 5 mg | 17108-5 | More Info |
| 13-OAHSA | A form of FAHFA in which oleic acid is esterified to 13-hydroxy stearic ac… | 1 mg | 17112-1 | More Info |
| 13-OAHSA | A form of FAHFA in which oleic acid is esterified to 13-hydroxy stearic ac… | 10 mg | 17112-10 | More Info |
| 13-OAHSA | A form of FAHFA in which oleic acid is esterified to 13-hydroxy stearic ac… | 5 mg | 17112-5 | More Info |
| 5-OAHSA | A FAHFA in which oleic acid is esterified at the 5th carbon of hydroxy ste… | 1 mg | 17115-1 | More Info |
| 5-OAHSA | A FAHFA in which oleic acid is esterified at the 5th carbon of hydroxy ste… | 10 mg | 17115-10 | More Info |
| 5-OAHSA | A FAHFA in which oleic acid is esterified at the 5th carbon of hydroxy ste… | 5 mg | 17115-5 | More Info |
| 9-OAHSA | A form of FAHFA in which oleic acid is esterified to 9-hydroxy stearic acid | 1 mg | 17039-1 | More Info |
| 9-OAHSA | A form of FAHFA in which oleic acid is esterified to 9-hydroxy stearic acid | 10 mg | 17039-10 | More Info |
| 9-OAHSA | A form of FAHFA in which oleic acid is esterified to 9-hydroxy stearic acid | 5 mg | 17039-5 | More Info |
| 12-OAHSA-d17 | An internal standard for the quantification of 12-OAHSA by GC- or LC-MS | 1 mg | 17195-1 | More Info |
| 12-OAHSA-d17 | An internal standard for the quantification of 12-OAHSA by GC- or LC-MS | 100 µg | 17195-100 | More Info |
| 12-OAHSA-d17 | An internal standard for the quantification of 12-OAHSA by GC- or LC-MS | 250 µg | 17195-250 | More Info |
| 12-OAHSA-d17 | An internal standard for the quantification of 12-OAHSA by GC- or LC-MS | 500 µg | 17195-500 | More Info |
| 5-OAHSA-d17 | An internal standard for the quantification of 5-OAHSA by GC- or LC-MS | 1 mg | 17198-1 | More Info |
| 5-OAHSA-d17 | An internal standard for the quantification of 5-OAHSA by GC- or LC-MS | 100 µg | 17198-100 | More Info |
| 5-OAHSA-d17 | An internal standard for the quantification of 5-OAHSA by GC- or LC-MS | 250 µg | 17198-250 | More Info |
| 5-OAHSA-d17 | An internal standard for the quantification of 5-OAHSA by GC- or LC-MS | 500 µg | 17198-500 | More Info |
| 2-O-(α-D-Glucopyranosyl)glycerol | A compatible solute; prevents drying-induced membrane fusion and CF leakag… | 1 g | 34492-1 | More Info |
| 2-O-(α-D-Glucopyranosyl)glycerol | A compatible solute; prevents drying-induced membrane fusion and CF leakag… | 10 g | 34492-10 | More Info |
| 2-O-(α-D-Glucopyranosyl)glycerol | A compatible solute; prevents drying-induced membrane fusion and CF leakag… | 5 g | 34492-5 | More Info |
| 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | An L-ascorbic acid derivative with antioxidant and radioprotective activit… | 10 g | 31402-10 | More Info |
| 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | An L-ascorbic acid derivative with antioxidant and radioprotective activit… | 25 g | 31402-25 | More Info |
| 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | An L-ascorbic acid derivative with antioxidant and radioprotective activit… | 5 g | 31402-5 | More Info |
| 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | An L-ascorbic acid derivative with antioxidant and radioprotective activit… | 50 g | 31402-50 | More Info |
| 2'(3')-O-(2-Aminoethylcarbamoyl)adenosine-5'-O-diphosphate (sodium salt) | A mixture of ADP derivatives | 2.6 mg | 38637-26 | More Info |
| 2(3')-O-(2-Aminoethylcarbamoyl)adenosine-5'-O-triphosphate (sodium salt) | A mixture of ATP derivatives | 3 mg | 38425-3 | More Info |
| 2'(3')-O-(6-Aminohexylcarbamoyl)adenosine-5'-O-triphosphate (sodium salt) | A mixture of ATP derivatives | 3.2 mg | 38810-32 | More Info |
| 2'(3')-O-(6-Aminohexylcarbamoyl)cytidine-5'-O-triphosphate (sodium salt) | A mixture of CTP derivatives | 3.1 mg | 38658-31 | More Info |
| 2'(3')-O-(6-Aminohexylcarbamoyl)guanosine-5'-O-diphosphate (sodium salt) | A mixture of GDP derivatives,, | 2.9 mg | 38429-29 | More Info |
| 2'(3')-O-(6-Aminohexylcarbamoyl)guanosine-5'-O-triphosphate (sodium salt) | A mixture of GTP derivatives; has been used in the synthesis of europium (… | 3.3 mg | 38659-33 | More Info |
| 2'(3')-O-(6-Aminohexylcarbamoyl)uridine-5'-O-triphosphate (sodium salt) | A mixture of UTP derivatives | 3.1 mg | 38660-31 | More Info |
| 2'(3')-O-Anthraniloyladenosine-5'-O-triphosphate (sodium salt) | Fluorescent ATP derivatives; inhibits mammalian AC1, AC2, and AC5 (Kis = 1… | 3.1 mg | 38546-31 | More Info |
| 3'-O-Anthraniloyl- 2'-deoxyadenosine-5'-O-triphosphate (sodium salt) | A fluorescent nucleotide derivative; inhibits B. pertussis and B. anthraci… | 600 µg | 38442-600 | More Info |
| 3'-O-Anthraniloyl-2'-deoxyguanosine-5'-O-triphosphate (sodium salt) | A fluorescent nucleotide derivative; has been used to probe inhibitor and… | 600 µg | 38547-600 | More Info |
| O-Arachidonoyl Ethanolamine (hydrochloride) | A constituent of human and rat brain in which the ethanolamine moiety is a… | 1 mg | 91050-1 | More Info |
| O-Arachidonoyl Ethanolamine (hydrochloride) | A constituent of human and rat brain in which the ethanolamine moiety is a… | 10 mg | 91050-10 | More Info |
| O-Arachidonoyl Ethanolamine (hydrochloride) | A constituent of human and rat brain in which the ethanolamine moiety is a… | 25 mg | 91050-25 | More Info |
| O-Arachidonoyl Ethanolamine (hydrochloride) | A constituent of human and rat brain in which the ethanolamine moiety is a… | 5 mg | 91050-5 | More Info |
| O-Arachidonoyl Glycidol | Selective inhibitor of monoacylglycerol hydrolysis; blocks 2-oleoyl glycer… | 10 mg | 10010547-10 | More Info |
| O-Arachidonoyl Glycidol | Selective inhibitor of monoacylglycerol hydrolysis; blocks 2-oleoyl glycer… | 100 mg | 10010547-100 | More Info |
| O-Arachidonoyl Glycidol | Selective inhibitor of monoacylglycerol hydrolysis; blocks 2-oleoyl glycer… | 5 mg | 10010547-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile